Artis BioSolutions

Artis BioSolutions operates an integrated platform for advanced therapy medicinal products (ATMPs), combining proprietary synthetic DNA production with downstream development and GMP manufacturing. The company eliminates fragmented supply chains by offering end-to-end services from synthetic DNA through clinical-grade manufacturing.

Core Capabilities

Synthetic DNA (oDNA Technology)

• Truly synthetic oDNA produced enzymatically to gram scale, free of biological contamination
• RUO and GMP grades available
• 2-week production timelines for RUO; 3–4 weeks for GMP
• Application-optimized linear dsDNA formats with specialized adapters
• No plasmid dependency at any stage

Modality Support

• mRNA
• Gene editing
• Viral vectors (including AAV)
• Cell therapies (including CAR-T)
• Vaccines
• Extracellular vesicles
• Emerging biologics

Manufacturing & Development

• Fully integrated services with disciplined end-to-end execution
• Single quality framework from development through GMP manufacturing
• Flexible engagement models: defined-scope execution to deep co-development partnerships
• Seamless technology transfer and continuity across development stages

Geographic Footprint

• GMP and RUO manufacturing in Watertown, MA (United States) and Bilbao, Spain (European Union)